Fermenta Biotech Ltd share price logo

Fermenta Biotech Ltd Share Price

339.00

+5.80

(+1.74%)

as on

bell
The current prices are delayed by 15 mins, login to check live prices.

Fermenta Biotech Ltd Stock Performance

as on September 5, 2025 at 4:01 pm IST

  • Day's Low

    Day's High

    ₹330.1
    ₹340
    downward going graph

    2.63%

    Downside

    0.29%

    Upside

    downward going graph
  • 52 Week's Low

    52 Week's High

    ₹219
    ₹449
    downward going graph

    35.40%

    Downside

    32.45%

    Upside

    downward going graph

Fermenta Biotech Ltd share price movements today

Previous Close
₹333.20
Open
₹335.00
Volume
11.82K
Upper Circuit
₹349.85
Lower Circuit
₹316.55
Day's Low - High
₹330.1 - ₹340
52 Week Low - High
₹219 - ₹449

Fermenta Biotech Ltd Historical Returns

1 Month Return
-5.16 %
3 Month Return
+ 3.95 %
1 Year Return
+ 16.4 %
3 Year Return
+ 33.47 %
5 Year Return
-18.82 %

Fermenta Biotech Ltd Fundamentals

as on September 5, 2025 at 4:01 pm IST

Market Cap

₹984.76 Cr

Return on Equity (ROE)

19.48

PE Ratio (TTM)

9.31

Return on capital employed (ROCE)

17.61

Industry PE ratio

42.41

Beta (LTM)

1.4

P/B Ratio

2.1

Dividend Yield

0.91

PEG Ratio

0.21

Quarterly Earnings Growth YOY

-464.25

EPS (TTM)

26.19

Sector

Pharmaceuticals

Book Value

124.33

Technical Analysis

Fermenta Biotech Ltd Stock Valuation

as on September 5, 2025 at 4:01 pm IST

Fermenta Biotech Ltd in the last 5 years

  • Overview

  • Trends

Lowest (-55.80x)

October 6, 2022

Today (9.31x)

September 5, 2025

Industry (42.41x)

September 5, 2025

Highest (473.02x)

September 6, 2022

LowHigh

Today’s Price to Earnings Ratio: 9.31x

Fermenta Biotech Ltd vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Fermenta Biotech Ltd with its industry peers.

Company
Analyst View
Market Cap(in ₹ Cr)
5 Year CAGRDebt to Asset Ratio
Net Profit(in ₹ Cr)
Yearly Revenue(in ₹ Cr)
NA984.76-3.76%0.6476469
NA749.9339.77%0.514211,280
NA944.8943.8%0.7510257
BUY8,260.4011.35%0.60781,286
NA238.2765.72%0.00NANA

Fermenta Biotech Ltd Stock's Interest Amongst Investors

Search interest for Fermenta Biotech Ltd Stock has decreased by -46% in the last 30 days, reflecting a downward trend in search activity.

Time period: to

Change:-46% versus previous 30 day period

Fermenta Biotech Ltd Quarterly Profit & Loss

Figures in Rupees Crores

Sep 2022
Dec 2022
Mar 2023
Jun 2023
Sep 2023
Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sales
98.03
54.86
105.16
82.45
56.91
98.97
97.34
78.13
95.03
156.47
139.85
136.26
Other Income
2.69
-
1.16
2.01
1.9
2.52
5.38
2.82
2.88
2.23
3.89
8.77
Total Income
100.72
54.86
106.32
84.46
58.8
101.49
102.72
80.95
97.91
158.7
143.74
145.03
Expenses
94.75
84.1
94.94
71.51
78.25
73.85
91.97
77.33
76.25
103.2
102.9
108.03
Operating Profit
3.28
-29.24
10.22
10.94
-21.34
25.12
5.37
0.8
18.78
53.27
36.95
28.23
Operating Profit Margin %
3.35%
-53.3%
9.72%
13.27%
-37.5%
25.38%
5.52%
1.02%
19.76%
34.04%
26.42%
20.72%
Profit Before Interest, Tax and Depreciation
5.97
-29.23
11.38
12.94
-19.45
27.64
10.76
3.62
21.66
55.5
40.84
37
Interest
4.86
5.14
6.31
4.78
3.69
5.19
3.39
3.43
3.69
4.08
2.99
3.11
Depreciation
9.07
6.32
6.19
5.95
5.93
6.38
6.46
6.12
6.15
6.08
5.86
5.81
Profit Before Tax
-7.96
-40.69
-1.12
2.21
-29.07
16.07
0.91
-5.93
11.82
45.34
31.99
28.08
Tax Paid
0.5
-3.05
4.18
-
-
6.08
8.05
-
0.7
7.45
-1.34
6.48
Profit After Tax
-8.46
-37.65
-5.29
2.21
-29.07
9.99
-7.14
-5.93
11.12
37.89
33.32
21.6
Total Net profit including share of profit / Loss from associate company
-8.46
-37.65
-5.29
2.21
-29.07
9.99
-7.14
-5.93
11.12
37.89
33.32
21.6
EPS
-2.8
-12.97
-1.42
0.64
-7.32
3.41
-2.41
-2.01
3.94
12.71
11.79
7.49
Actual EPS
-2.8
-12.97
-1.42
0.64
-7.32
3.41
-2.41
-2.01
3.94
12.71
11.79
7.49
Adjusted EPS
-2.8
-12.97
-1.42
0.64
-7.32
3.41
-2.41
-2.01
3.94
12.71
11.79
7.49
Diluted EPS
-2.8
-12.97
-1.42
0.64
-7.32
3.41
-2.41
-2.01
3.94
12.71
11.79
7.47

Fermenta Biotech Ltd Annual Profit & Loss

Figures in Rupees Crores

Mar 2017
Mar 2018
Mar 2019
Mar 2020
Mar 2021
Mar 2022
Mar 2023
Mar 2024
Mar 2025
Sales
164.13
302.67
404.67
292.95
377.29
398.52
349.94
335.66
469.48
Other Income
2.78
8.95
12.37
12.32
8.25
8.14
8.6
11.81
11.82
Total Income
166.91
311.62
417.04
305.27
385.54
406.65
358.54
347.47
481.3
Expenses
152.17
209.65
253.31
237.76
295.63
337.06
360.81
315.58
359.68
Operating Profit
11.96
93.02
151.36
55.19
81.66
61.46
-10.87
20.08
109.8
Operating Profit Margin %
7.29%
30.73%
37.4%
18.84%
21.64%
15.42%
-3.11%
5.98%
23.39%
Profit Before Interest, Tax and Depreciation
14.75
101.97
163.72
67.51
89.91
69.59
-2.28
31.89
121.62
Interest
9.96
13.63
23.13
9.09
17.97
17.08
20.78
17.05
14.19
Depreciation
10.31
12.36
11.89
15
20.31
25.56
28.25
24.72
24.22
Profit Before Tax
-5.52
75.98
128.7
43.42
51.63
26.95
-51.31
-9.88
83.21
Tax Paid
2.7
21.13
10.81
-16.1
9.1
11.89
1.83
14.14
6.8
Profit After Tax
-8.23
54.84
117.9
59.52
42.53
15.06
-53.13
-24.01
76.4
Total Net profit including share of profit / Loss from associate company
-8.62
46.35
117.47
59.52
42.53
15.06
-53.13
-24.01
76.4
EPS
-49.82
36.75
40.72
20.63
15.77
5.35
-17.7
-5.42
26.35
Actual EPS
-49.82
36.75
40.72
20.63
15.77
5.35
-17.7
-5.42
26.35
Adjusted EPS
-4.15
3.06
13.57
20.63
15.77
5.35
-17.7
-5.42
26.35
Diluted EPS
-49.82
36.75
40.7
20.53
15.69
5.33
-17.7
-5.42
26.35

Fermenta Biotech Ltd Cash Flow

Figures in Rupees Crores

Mar 2016
Mar 2017
Mar 2018
Mar 2019
Mar 2020
Mar 2021
Mar 2022
Mar 2023
Mar 2024
Mar 2025
Net Cash from Operating Activities
4.44
1.91
59.26
90.34
34.46
62.6
43.44
116.11
105.35
40.9
Cash Flow from Investing Activities
-13.38
6.53
-101.14
-96.58
-43.66
-40.94
-26.04
-55.35
-15.5
-0.15
Cash Flow from Financing Activities
10.42
-12.11
88.81
12.21
-47.44
-1.14
-21.58
-41.38
-90.86
-50.86
Net Cash Flow
1.48
-3.68
46.93
5.99
-56.65
20.52
-4.17
19.37
-1
-10.12

Fermenta Biotech Ltd Stock Shareholding Pattern

Numbers in percentages

Sep 2022
Dec 2022
Mar 2023
Jun 2023
Sep 2023
Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Promoters
59.58%
59.58%
59.58%
62.06%
62.06%
62.06%
62.06%
62.06%
62.06%
62.06%
64.09%
64.09%
DII
0.05%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
FII
0%
0%
0%
0%
0%
0%
0%
0%
0.05%
0.02%
0.02%
0.02%
Public
38.37%
38.46%
38.47%
36.02%
36.05%
36.05%
36.05%
36.11%
36.42%
36.97%
35%
35%
Total Outstanding Shares
2,94,30,987
2,94,30,987
2,94,30,987
2,94,30,987
2,94,30,987
2,94,30,987
2,94,30,987
2,94,30,987
2,94,30,987
2,94,30,987
2,94,30,987
2,94,30,987
Total Shareholders
17,971
17,610
16,897
16,148
15,721
15,150
15,178
14,589
13,221
12,922
12,930
12,845

Fermenta Biotech Ltd Earnings and Dividends

View detailed summary of the earnings and dividend history of Fermenta Biotech Ltd.

  • Fermenta Biotech Ltd Earnings Results

    Fermenta Biotech Ltd’s net profit jumped 475.09% since last year same period to ₹21.83Cr in the Q1 2025-2026. On a quarterly growth basis, Fermenta Biotech Ltd has generated -36.52% fall in its net profits since last 3-months.

    Read More about Earnings Results
  • Fermenta Biotech Ltd Dividends May,2025

    In the quarter ending March 2025, Fermenta Biotech Ltd has declared dividend of ₹2.50 per share on 28 May 2025 - translating a dividend yield of 0.74%.

    Read More about Dividends

Insights on Fermenta Biotech Ltd

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgPOSITIVE IMPACT

    Revenue Rich

    img

    Revenue is up for the last 2 quarters, 143.74 Cr → 145.03 Cr (in ₹), with an average increase of 0.9% per quarter

  • imgPOSITIVE IMPACT

    Price Rise

    img

    In the last 7 days, Fermenta Biotec. stock has moved up by 3.7%

  • imgNO EFFECT

    FII Holding Unchanged

    img

    Foreign Institutions holdings remained unchanged at 0.02% of holdings in Jun 2025 quarter

  • imgNO EFFECT

    Promoter Holding Unchanged

    img

    Promoters holdings remained unchanged at 64.09% of holdings in Jun 2025 quarter

  • imgNO EFFECT

    Against Peers

    img

    In the last 1 year, Divis Laboratories Ltd has given 17.0% return, outperforming this stock by 0.6%

  • imgNO EFFECT

    Retail Holding Unchanged

    img

    Retail Investor holdings remained unchanged at 35.00% of holdings in Jun 2025 quarter

  • imgNO EFFECT

    Against Peers

    img

    In the last 3 years, Torrent Pharmaceuticals Ltd has given 138.2% return, outperforming this stock by 104.7%

  • imgNEGATIVE IMPACT

    Profit Down

    img

    Netprofit is down for the last 3 quarters, 36.91 Cr → 21.83 Cr (in ₹), with an average decrease of 21.7% per quarter

About Fermenta Biotech Ltd

DupharInterfran (DIL) was established by a technocrat, D V K Raju in 1951 as International Franchises Pvt Ltd. In the early years, the company manufactured and sold toothpaste, antiseptic lotion and pharmaceutical specialities on a loan licence basis, in collaboration with PhilipsDuphar Amsterdam Solvay Duphar and Crookes Laboratories London (participation up to 25% equity). The company changed its name to Crookes Interfran in 1963 and to DupharInterfran in 1971. In 1976, collaborations with Solvay Duphar for manufacturing Vitamin D3 and Isoxypurine hydrochloride, with 38.86% foreign stake, came up. In 1995, DIL launched a rights issue to increase long-term resources and working capital and sold two popular brands - Crocin and LactoCalamine lotion - to Smithkline Beecham Pharmaceuticals and Nicholas Piramal respectively to concentrate on the core business of ethical drugs. As per the Scheme of Arrangement, the pharma business of the company was also transferred to a new entity called Duphar Pharma India and investments in unutilised premises at Thane for a commercial complex with modern facilities were also made. In 2003, the Company expanded manufacturing capacity for Vitamin D and other products like Phenyramidol in Kullu. In 2010, the company signed a contract with Solvay Pharmaceuticals B V in Netherlands and acquired 990000 equity shares of Rs.10 each from Fermenta Biotech Ltd, making it a subsidiary. In 2012, the company launched Penicillin G Acylase catalyst Fermase PA 850 and successful entries of Annual Contract with Solvay Pharmaceuticals B V, a vasodilator. Since then, the company has launched new and improved products - fish oil derived cholesterol for the aquaculture market, Vitamin D 500 feed grade powder in 2020, Vitamin AD2 for oil fortification, and patented technology for enzymatic synthesis of Molnupiravir in 2021. It also established subsidiaries in Mauritius, Germany, and USA. The company changed its name from DIL Limited to Fermenta Biotech Limited (FBL) in 2019.

Revenue: ₹136.26Cr as on June 2025 (Q1 FY26)
Net Profit: ₹21.60Cr as on June 2025 (Q1 FY26)
Chairperson Name: Pradeep Manjunath Chandan
OrganisationFermenta Biotech Ltd
IndustryPharmaceuticals
CEOPradeep Manjunath Chandan
E-voting on sharesClick here to vote

FAQs

What is Fermenta Biotech Ltd share price today?

Fermenta Biotech Ltd share price today stands at ₹339 as on at the close of the market. Fermenta Biotech Ltd share today touched a day high of ₹340 and a low of ₹330.1.

What is the 52 week high and 52 week low range for Fermenta Biotech Ltd share?

Fermenta Biotech Ltd touched a 52 week high of ₹449 and a 52 week low of ₹219. Fermenta Biotech Ltd share price today i.e. is closed at ₹339, which is -24.50% down from its 52 week high and 54.79% up from its 52 week low.

What is Fermenta Biotech Ltd's market capitalisation today?

Fermenta Biotech Ltd market capitalisation is ₹984.76 Cr as on .

How to buy Fermenta Biotech Ltd shares?

To buy Fermenta Biotech Ltd shares, you need to follow these steps:

  • Open a Demat account and Trading account on INDmoney
  • Fund your Trading account
  • Search for 506414 or Fermenta Biotech Ltd on the INDmoney app to check live prices of the stock
  • Click on Buy or SIP to place an order to invest in Fermenta Biotech Ltd shares. You can invest by selecting the number of shares or set up a fixed SIP to invest every month or week.

What is Fermenta Biotech Ltd trading volume today?

Fermenta Biotech Ltd trading volume is 11.82K as on . This means that 11.82K shares of Fermenta Biotech Ltd were bought and sold on the stock market during today's trading session.